BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37539662)

  • 1. Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.
    Szabo R; Kawaguchi M; Kataoka H; Bugge TH
    Development; 2023 Sep; 150(17):. PubMed ID: 37539662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy.
    Szabo R; Callies LK; Bugge TH
    Development; 2019 Nov; 146(22):. PubMed ID: 31628112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.
    Wu CJ; Feng X; Lu M; Morimura S; Udey MC
    J Clin Invest; 2017 Feb; 127(2):623-634. PubMed ID: 28094766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy.
    Szabo R; Bugge TH
    PLoS One; 2018; 13(4):e0194660. PubMed ID: 29617460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
    Wu CJ; Lu M; Feng X; Nakato G; Udey MC
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy.
    Das B; Okamoto K; Rabalais J; Kozan PA; Marchelletta RR; McGeough MD; Durali N; Go M; Barrett KE; Das S; Sivagnanam M
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G580-G591. PubMed ID: 31433211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.
    Salomon J; Goulet O; Canioni D; Brousse N; Lemale J; Tounian P; Coulomb A; Marinier E; Hugot JP; Ruemmele F; Dufier JL; Roche O; Bodemer C; Colomb V; Talbotec C; Lacaille F; Campeotto F; Cerf-Bensussan N; Janecke AR; Mueller T; Koletzko S; Bonnefont JP; Lyonnet S; Munnich A; Poirier F; Smahi A
    Hum Genet; 2014 Mar; 133(3):299-310. PubMed ID: 24142340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine.
    Kawaguchi M; Yamamoto K; Takeda N; Fukushima T; Yamashita F; Sato K; Kitamura K; Hippo Y; Janetka JW; Kataoka H
    Commun Biol; 2019; 2():11. PubMed ID: 30623107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.
    Holt-Danborg L; Vodopiutz J; Nonboe AW; De Laffolie J; Skovbjerg S; Wolters VM; Müller T; Hetzer B; Querfurt A; Zimmer KP; Jensen JK; Entenmann A; Heinz-Erian P; Vogel LK; Janecke AR
    Hum Mol Genet; 2019 Mar; 28(5):828-841. PubMed ID: 30445423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of Italian patients with congenital tufting enteropathy.
    d'Apolito M; Pisanelli D; Faletra F; Giardino I; Gigante M; Pettoello-Mantovani M; Goulet O; Gasparini P; Campanozzi A
    World J Pediatr; 2016 May; 12(2):219-24. PubMed ID: 26684320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
    Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
    PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.
    Barndt RB; Lee MJ; Huang N; Lu DD; Lee SC; Du PW; Chang CC; Tsai PB; Huang YK; Chang HM; Wang JK; Lai CH; Johnson MD; Lin CY
    Hum Mol Genet; 2021 Sep; 30(19):1833-1850. PubMed ID: 34089062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.
    Guerra E; Lattanzio R; La Sorda R; Dini F; Tiboni GM; Piantelli M; Alberti S
    PLoS One; 2012; 7(11):e49302. PubMed ID: 23209569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Epithelial Differentiation Contributes to Pathogenesis in a Murine Model of Congenital Tufting Enteropathy.
    Das B; Okamoto K; Rabalais J; Young JA; Barrett KE; Sivagnanam M
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1353-1371. PubMed ID: 34198013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase.
    Ouchi T; Morimura S; Dow LE; Miyoshi H; Udey MC
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.
    Szabo R; Hobson JP; Christoph K; Kosa P; List K; Bugge TH
    Development; 2009 Aug; 136(15):2653-63. PubMed ID: 19592578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.
    Szabo R; Ward JM; Artunc F; Bugge TH
    Biol Open; 2022 Jul; 11(7):. PubMed ID: 35730316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.
    Kozan PA; McGeough MD; Peña CA; Mueller JL; Barrett KE; Marchelletta RR; Sivagnanam M
    J Mol Med (Berl); 2015 May; 93(5):535-45. PubMed ID: 25482158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of EpCam mutation in mice and men.
    Mueller JL; McGeough MD; Peña CA; Sivagnanam M
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G278-88. PubMed ID: 24337010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.